基於細胞的檢測和高內涵篩選市場：按使用者、產品進行預測 - 附執行顧問指南（2024-2028）

基於細胞的檢測是藥物開發和科學研究的支柱，目前正在恢復大流行後研究活動。 此外，新技術允許使用基於細胞的測定來測量細胞功能的各個方面。 這個市場還在不斷成長。 製藥業的支柱正成為生物技術的核心。

本報告考察了全球細胞檢測和高內涵篩選市場，提供了市場概述、使用者趨勢、產品以及參與市場的公司概況。

目錄

第一章市場指南

第 2 章介紹與市場定義

• 什麼是基於細胞的檢測？
• 臨床試驗失敗
• 傳染病所扮演的角色
• 市場定義
• 調查方法
• 美國醫療保健市場與藥物研究支出
• 觀點

第 3 章基於細胞的測定 - 技術指南

• 細胞培養
• 細胞分析
• 細胞活力測定
• 細胞增殖檢測
• 細胞毒性測定
• 細胞老化檢測
• 細胞凋亡
• 自噬
• 壞死
• 氧化應激
• 2D 和 3D
• 訊號傳導途徑，GPCR
• 免疫調節和抑制
• 記者基因科技
• CBA 設計與開發
• 基於細胞的檢測 - 要點

第四章產業概論

• 市場准入組織
  • 學術研究所
  • 合約研究組織
  • 基因組設備供應商
  • 細胞分離與觀察供應商
  • 細胞株和試劑供應商
  • 製藥公司
  • 審計機構
  • 認證機構

第五章市場趨勢

• 生長促進因素
• 抑制生長的因素
• 技術開發

第 6 章基於細胞的檢測的最新進展

第七章主要公司簡介

• Abcam
• Agilent
• Aurora Biomed
• Axxam
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• Berkley Lights
• BioIVT
• Bio-Rad Laboratories, Inc.
• BMG Labtech
• Bruker
• Cell Biolabs, Inc.
• Cell Signaling Technology, Inc.
• Charles River Laboratories
• Corning, Inc.
• Cytek Biosciences
• Cytovale
• Deepcell
• Enzo Biochem
• Eurofins DiscoverX Corporation
• Evotec AG
• Excellerate Bioscience
• Fujifilm Cellular Dynamics International
• Genedata
• Hemogenix
• Invivogen
• Leica Biosystems
• Lonza Group Ltd.
• Luminex Corp（DiaSorin）
• Merck & Co., Inc
• Miltenyi Biotec
• Molecular Devices
• Nanion
• Ncardia
• New England Biolabs, Inc.
• Novogene Bioinformatics Technology Co., Ltd.
• Olympus
• Origene Technologies
• Promega
• Qiagen
• Reaction Biology
• Recursion Pharma
• Revvity
• Roche Diagnostics
• Sartorius
• Sartorius-ForteBio
• Sartorius-IntelliCyt
• Singleron Biotechnologies
• Sony Biotechnology
• SPT Labtech
• Stemcells Technologies Canada Inc.
• Tecan
• Thermo Fisher Scientific Inc.
• Vitro Biopharma

第 8 章世界市場規模

• 國家 - 概述
• 按使用者 - 概述
• 依產品類別 - 概述

第 9 章全球市場，依使用者類型劃分

• 醫藥
• 研究
• 工業/化妝品

第 10 章基於細胞的測定，依產品類別

• 設備
• 試劑
• 服務
• 軟體

第11章附錄

OVERVIEW:

Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is rebounding. On top of this new technology is allowing Cell Based Assays to be used to measure any aspect of cell function. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

• B.Sc. (Chemistry) University of BC
• M.B.A. (Finance and Policy) University of BC
• Market Research Seminar - Burke Institute
• Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

• 1.1. Situation Analysis
• 1.2. Guide for Executives and Marketing Staff
• 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

• 2.1. What are Cell Based Assays?
• 2.2. Clinical Trial Failures
  • 2.2.1. Immuno-oncology Plays a Leading Role in Cell Based Assays
• 2.3. Infectious Disease Will Play a Larger Role
• 2.4. Market Definition
  • 2.4.1. Market Size
  • 2.4.2. Currency
  • 2.4.3. Years
• 2.5. Methodology
  • 2.5.1. Methodology
  • 2.5.2. Sources
  • 2.5.3. Authors
• 2.6. U.S. Medical Market and Pharmceutical Research Spending -
• Perspective
  • 1.5.1. U.S. Expenditures for Pharmaceutical Research

3. Cell Based Assays-Guide to Technology

• 3.1. Cell Cultures
  • 3.1.1. Cell Lines
  • 3.1.2. Primary Cells
  • 3.1.3. Stem Cells
  • 3.1.4. iPSC's-The Special Case
• 3.2. Cell Assays
• 3.3. Cell Viability Assays
• 3.4. Cell Proliferation Assays
• 3.5. Cytotoxicity Assays
• 3.6. Cell Senescence Assays
• 3.7. Apoptosis
• 3.8. Autophagy
• 3.9. Necrosis
• 3.10. Oxidative Stress
• 3.11. 2D vs. 3D
• 3.12. Signalling Pathways, GPCR
• 3.13. Immune Regulation & Inhibition
• 3.14. Reporter Gene Technology
• 3.15. CBA Design & Development
• 3.16. Cell Based Assays-The Takeaway

4. Industry Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Contract Research Organization
  • 4.1.3. Genomic Instrumentation Supplier
  • 4.1.4. Cell Separation and Viewing Supplier
  • 4.1.5. Cell Line and Reagent Supplier
  • 4.1.6. Pharmaceutical Company
  • 4.1.7. Audit Body
  • 4.1.8. Certification Body

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. Candidate Growth
  • 5.1.2. Immuno-oncology
  • 5.1.3. Genomic Blizzard
  • 5.1.4. Technology Convergence
  • 5.1.5. The Insurance Effect
• 5.2. Factors Limiting Growth
  • 5.2.1. CBA Development Challenges
  • 5.2.2. Instrument Integration
  • 5.2.3. Protocols
• 5.3. Technology Development
  • 5.3.1. 3D Assays
  • 5.3.2. Automation
  • 5.3.3. Software
  • 5.3.4. Primary Cells
  • 5.3.5. Signalling and Reporter Genes
  • 5.3.6. The Next Five Years

6. Cell Based Assays Recent Developments

• 6.1. Recent Developments-Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. Castle Biosciences Sees Big Gains in New Testing Niches
• 6.3. Cell-Based Assay Outperforms Others
• 6.4. 3D spheroid model Monitors T-cell invasion
• 6.5. BioAuxilium Launches New Biomarker Assay
• 6.6. Charles River Laboratories Acquires SAMDI Tech
• 6.7. Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform
• 6.8. Fujifilm's Life Sciences Invests in PhenoVista Biosciences
• 6.9. Nucleai Launches New Multiplex Imaging Spatial Analysis Solution
• 6.10. BIO-TECHNE ANNOUNCES MULTI-OMIC RNASCOPE ASSAYS
• 6.11. Indivumed, CellPhenomics Partner on Cancer Drug Target Research
• 6.12. Synthego to Accelerate Drug Discovery
• 6.13. Long COVID Detected By Cell-Based Assay
• 6.14. Nanolive closes a USD 20 million Funding Round
• 6.15. Depixus Seeks to Commercialize 'Magnetic Tweezers' for Drug Discovery
• 6.16. BioAuxilium Research Expands its Cell Signaling Assay Portfolio
• 6.17. Droplet Genomics Debuts New Microfluidic Screening Platform
• 6.18. DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
• 6.19. Secondcell Bio to Make Creation of Cell Lines Easy
• 6.20. Nanolitre-scale cell assays developed with droplet microarraymass spec
• 6.21. Thermo Fisher Scientific Acquires Cell Sorting Technology
• 6.22. Cellink to Distribute Phasefocus High-Content Cell Imaging Platform
• 6.23. Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
• 6.24. Cancer Genetics to Acquire Organoid Startup Stemonix
• 6.25. Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
• 6.26. CRISPR Screens Uncover Novel Cancer Therapy Targets
• 6.27. ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

7. Profiles of Key Cell Based Assay Companies

• 7.1. Abcam
• 7.2. Agilent
• 7.3. Aurora Biomed
• 7.4. Axxam
• 7.5. Beckman Coulter Diagnostics
• 7.6. Becton, Dickinson and Company
• 7.7. Berkley Lights
• 7.8. BioIVT
• 7.9. Bio-Rad Laboratories, Inc.
• 7.10. BMG Labtech
• 7.11. Bruker
• 7.12. Cell Biolabs, Inc.
• 7.13. Cell Signaling Technology, Inc.
• 7.14. Charles River Laboratories
• 7.15. Corning, Inc.
• 7.16. Cytek Biosciences
• 7.17. Cytovale
• 7.18. Deepcell
• 7.19. Enzo Biochem
• 7.20. Eurofins DiscoverX Corporation
• 7.21. Evotec AG
• 7.22. Excellerate Bioscience
• 7.23. Fujifilm Cellular Dynamics International
• 7.24. Genedata
• 7.25. Hemogenix
• 7.26. Invivogen
• 7.27. Leica Biosystems
• 7.28. Lonza Group Ltd.
• 7.29. Luminex Corp (DiaSorin)
• 7.30. Merck & Co., Inc
• 7.31. Miltenyi Biotec
• 7.32. Molecular Devices
• 7.33. Nanion
• 7.34. Ncardia
• 7.35. New England Biolabs, Inc.
• 7.36. Novogene Bioinformatics Technology Co., Ltd.
• 7.37. Olympus
• 7.38. Origene Technologies
• 7.39. Promega
• 7.40. Qiagen
• 7.41. Reaction Biology
• 7.42. Recursion Pharma
• 7.43. Revvity
• 7.44. Roche Diagnostics
• 7.45. Sartorius
• 7.46. Sartorius-ForteBio
• 7.47. Sartorius-IntelliCyt
• 7.48. Singleron Biotechnologies
• 7.49. Sony Biotechnology
• 7.50. SPT Labtech
• 7.51. Stemcells Technologies Canada Inc.
• 7.52. Tecan
• 7.53. Thermo Fisher Scientific Inc.
• 7.54. Vitro Biopharma

8. Global Market Size

• 8.1. Global Market Overview by Country
  • 8.1.1. Table-Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by User - Overview
  • 8.2.1. Table-Global Market by User
  • 8.2.2. Chart-Global Market by User-Base/End Year Comparison
  • 8.2.3. Chart-Global Market by User-Base Year
  • 8.2.4. Chart-Global Market by User-End Year
  • 8.2.5. Chart-Global Market by User-Share by Year
• 8.3. Global Market by Product Class - Overview
  • 8.3.1. Table-Global Market by Product Class
  • 8.3.2. Chart-Global Market by Product Class-Base/End Year Comparison
  • 8.3.3. Chart-Global Market by Product Class-Base Year
  • 8.3.4. Chart-Global Market by Product Class-End Year
  • 8.3.5. Chart-Global Market by Product Class-Share by Year

9. Global Market by User Type

• 9.1. Pharma
  • 9.1.1. Table Pharma-by Country
  • 9.1.2. Chart - Pharma Growth
• 9.2. Research
  • 9.2.1. Table Research-by Country
  • 9.2.2. Chart - Research Growth
• 9.3. Industry/Cosmetic
  • 9.3.1. Table Industry/Cosmetic-by Country
  • 9.3.2. Chart - Industry/Cosmetic Growth

10. Cell Based Assay by Product Class

• 10.1. Instrument
  • 10.1.1. Table Instrument-by Country
  • 10.1.2. Chart - Instrument Growth
• 10.2. Reagent
  • 10.2.1. Table Reagent-by Country
  • 10.2.2. Chart - Reagent Growth
• 10.3. Services
  • 10.3.1. Table Services-by Country
  • 10.3.2. Chart - Services Growth
• 10.4. Software
  • 10.4.1. Table Software-by Country
  • 10.4.2. Chart - Software Growth

11. Appendices

• 11.1. FDA Cancer Drug Approvals by Year
• 11.2. Clinical Trials Started
• 11.3. Share of Pharma R&D by Country

Table of Tables

• Table 1: The Large Variety of Cell Lines
• Table 2: Some Common Viability Assays
• Table 3: Oxidative Stress Related Diseases
• Table 4: Important Signalling Pathways
• Table 5: Market Players by Type
• Table 6: Five Factors Driving Growth
• Table 7: Three Factors Limiting Growth
• Table 8: - Global Market by Region
• Table 9: Global Market by User
• Table 10: Global Market by Product Class
• Table 11: Pharma by Country
• Table 12: Research by Country
• Table 13: Industry/Cosmetic by Country
• Table 14: Instrument by Country
• Table 15: Reagent by Country
• Table 16: Services by Country
• Table 17: Software by Country

Table of Figures

• Figure 1: Reasons for clinical Failure by Phase
• Figure 2: Immunotherapy Clinical Trial Growth
• Figure 3: Pharmaceutical Research Expenditures ($Billion)
• Figure 4: Oxidative Stress and Free Radical Toxicity
• Figure 5: FDA Cancer Drug Approvals
• Figure 6: The Changing Approach to Cancer Diagnostics
• Figure 7: Growth rates of Cell Based Assays by Product Class
• Figure 8: Global Market Share Chart
• Figure 9: Global Market by User-Base vs. End Year
• Figure 10: Global Market by User Base Year
• Figure 11: Global Market by User End Year
• Figure 12: User Share by Year
• Figure 13: Global Market by Product Class-Base vs. End Year
• Figure 14: Global Market by Product Class Base Year
• Figure 15: Global Market by Product Class End Year
• Figure 16: Product Class Share by Year
• Figure 17: Pharma Growth
• Figure 18: Research Growth
• Figure 19: Industry/Cosmetic Growth
• Figure 20: Instrument Growth
• Figure 21: Reagent Growth
• Figure 22: Services Growth
• Figure 23: Software Growth
• Figure 24: FDA Cancer Drug Approvals by Year
• Figure 25: Clinical Trials for Immunotherapy by Year
• Figure 26: Share of Pharma R&D by Country